Xponance, Inc. Axsome Therapeutics, Inc. Transaction History
Xponance, Inc.
- $10.2 Billion
- Q3 2024
A detailed history of Xponance, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 2,382 shares of AXSM stock, worth $243,607. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,382Holding current value
$243,607% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
326Shares Held
37.8MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$428 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$409 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$337 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$241 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$107 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.39B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...